Literature DB >> 33685465

Correction to: The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.

Mathieu Blot1,2, Jean-Baptiste Bour3, Jean Pierre Quenot4,5,6,7, Abderrahmane Bourredjem6,7, Maxime Nguyen4,8, Julien Guy9, Serge Monier4,10, Marjolaine Georges11, Audrey Large5, Auguste Dargent4,5, Alexandre Guilhem12, Suzanne Mouries-Martin13, Jeremy Barben14, Belaid Bouhemad4,8, Pierre-Emmanuel Charles4,5, Pascal Chavanet15,6,7, Christine Binquet4,6,7, Lionel Piroth15,6,7.   

Abstract

Entities:  

Year:  2021        PMID： 33685465     DOI： 10.1186/s12967-021-02746-0

Source DB:  PubMed          Journal:  J Transl Med        ISSN： 1479-5876            Impact factor:   5.531


× No keyword cloud information.
  1 in total

1.  The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome.

Authors:  Mathieu Blot; Jean-Baptiste Bour; Jean Pierre Quenot; Abderrahmane Bourredjem; Maxime Nguyen; Julien Guy; Serge Monier; Marjolaine Georges; Audrey Large; Auguste Dargent; Alexandre Guilhem; Suzanne Mouries-Martin; Jeremy Barben; Belaid Bouhemad; Pierre-Emmanuel Charles; Pascal Chavanet; Christine Binquet; Lionel Piroth
Journal:  J Transl Med       Date:  2020-12-03       Impact factor: 5.531
  1 in total
  2 in total

Review 1.  The Role of Nuclear Factor Kappa B (NF-κB) in Development and Treatment of COVID-19: Review.

Authors:  Monika Gudowska-Sawczuk; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 2.  Modulation of Host Immune Response Is an Alternative Strategy to Combat SARS-CoV-2 Pathogenesis.

Authors:  Lakhveer Singh; Sakshi Bajaj; Manoj Gadewar; Nitin Verma; Mohd Nazam Ansari; Abdulaziz S Saeedan; Gaurav Kaithwas; Manjari Singh
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.